Does Cavβ3 subunit confer neuroprotection in chronic inflammatory CNS disease?
Does Cavβ3 subunit confer neuroprotection in chronic inflammatory CNS disease?
批准号:
280871652
负责人:
Professorin Dr. Ricarda Diem
金额:
$0.0万
依托单位:
依托单位国家:
德国
项目类别:
Research Units
财政年份:
2015
资助国家:
德国
项目状态:
已结题
起止时间:
2014-12-31 至 2022-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The β subunit type 3 of voltage-gated Ca2+ channels (Cavβ3) has traditionally been understood to exclusively function as a regulatory subunit of Cav channels, especially of Cav2.2 (N-type) channels, in neurons. However, we recently described a novel role as a regulator of intracellular inositol 1,4,5-trisphosphate receptor (IP3R)-dependent Ca2+ release, thus furthering our understanding of its functions in non-neuronal cells. During the first funding period of the Research Unit, we showed through global and cell-specific knockouts that Cavβ3 determines the disease progression of experimental autoimmune encephalomyelitis (EAE), a model of multiple sclerosis. Cavβ3 global knockouts developed more severe EAE than their respective wild-types, characterised by increased immune cell infiltration in the spinal cord and the optic nerves, but also increased blood-brain barrier (BBB) permeability already in “healthy” knockouts. The EAE phenotype of the global Cavβ3 knockout was not apparent in neuron- or T cell-specific Cavβ3 knockouts, but was mirrored in both astrocyte- and endothelial-specific knockouts. Astrocytes and endothelial cells contribute to the maintenance of the BBB and in order to further our understanding of how Cavβ3 is involved in the progression of EAE we will investigate possible Cavβ3 functions in these cells by immunohistochemical and ultrastructural analysis in situ and BBB models in vitro and pursue strategies to boost the beneficial effect of Cavβ3 on disease progression in vivo.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Coordination Funds
-
批准号:280876010
-
项目类别:Research Units
-
资助金额:$0.0万
-
财政年份:2015
-
负责人:Professorin Dr. Ricarda Diem
-
依托单位:
Wirkt die CaVbeta3-Untereinheit protektiv bei chronisch entzündlichen ZNS-Erkrankungen?
-
批准号:213385462
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2012
-
负责人:Professorin Dr. Ricarda Diem
-
依托单位:
国内基金
海外基金
登录
查看更多内容
PIAS1通过增加KDM6A SUMO化修饰表观下调CAV1抑制铁死亡在急性肺损伤中的机制研究
-
批准号:2026JJ80669
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈阳晔
-
依托单位:
TET2去甲基化上调CAV1表达介导PGR泛素化降解在妊娠期显性糖尿病并发子痫前期蜕膜化障碍中的作用及干预研究
-
批准号:JCZRLH202600862
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
Cav-1/ANXA2通过激活自噬缓解内质网应激改善急性肾损伤的作用及机制研究
-
批准号:2026JJ60573
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:孙丽雅
-
依托单位:
氢吗啡酮-罗哌卡因通过调控神经元-胶质细胞中Cav2.3通路和钠-钙交换体而缓解骨癌痛中爆发痛的作用机制研究
-
批准号:2026JJ82462
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:张先红
-
依托单位:
靶向电压门控钙通道CaV2.2的新一代多肽毒素镇痛药物与策略研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:唐城
-
依托单位:
芪冬颐心颗粒通过抑制m6A甲基化调控CAV1和SCN5A表达改善室性早搏的研究
-
批准号:2026JJ81315
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:陈艳玲
-
依托单位:
Cav-1通过SERCA2a调控肾小管上皮细胞内质网应激在急性肾损伤中的作用及机制研究
-
批准号:2026JJ50629
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:谢艳云
-
依托单位:
补阳还五汤介导Cav1抑制mtDNA/cGAS/STING轴促进小胶质细胞胞葬拮抗卒中后认知障碍的机制研究
-
批准号:2026JJ60253
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:欧阳银
-
依托单位:
YAP通过β-Catenin的协同作用和调节ANKRD1、CAV1调控肝内胆管癌转移的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:张艺
-
依托单位:
CAV2/CAV1通过调节Focal adhesion信号通路抑制鼻咽癌放疗抵抗的机制研究
-
批准号:JCZRLH202500859
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位: